“… Clinical Features | Genotype | Mutation | Organelle Alterations * | Reference |
Cone-rod dystrophy, spastic paraparesis, leukodystrophy | c.1205 + 1G>A (p.G402DfsX5) homozygous | Frame shift, truncation No detectable ACBD5 protein | Impaired β-oxidation of VLCFA in peroxisomes, normal plasmalogen synthesis | [ 137 , 143 ] |
Retinal dystrophy, progressive leukodystrophy and microcephaly, ataxia, dysarthria, hypomyelination with diffuse abnormality in deep white matter | c.626-689_937-234delins936+1075_c.936+1230inv (p.D208VfsX30) homozygous | Exon 7/8 deletion No detectable ACBD5 protein | Normal presence of import-competent peroxisomes. Increased VLCFA levels, reduced C26:0 β-oxidation, reduced plasmalogen biosynthesis | [ 76 , 140 , 142 ] |
Leukodystrophy, nystagmus, cone-rod dystrophy, spastic paraparesis, psychomotor developmental regression | c.1467G>A, (p.W489X) homozygous | Nonsense mutation, truncation | Elevated C26:0, C24:0/C22:0, and C26:0/C22:0 in plasma, decreased C22:0, C24:0 levels and phytanic acid in plasma | [ 138 ] |
Leukodystrophy, retinal dystrophy, nystagmus | c.1297C>T, (p.R433X) homozygous | Nonsense mutation, truncation Very little detectable ACBD5 protein | Elevated C26:0 in plasma (patient 1), elevated C24:0 and C22:0 in plasma (patient 2) | [ 139 ] |
…”